Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Aug-2025 02:11 ET (1-Aug-2025 06:11 GMT/UTC)
This meta-analysis provides preliminary evidence supporting the use of fecal microbiota transplantation (FMT) as a strategy to enhance the efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced or refractory solid tumors.
Researchers decode how liver fibrosis progresses to cancer, identifying key cellular drivers and signaling pathways. The review highlights promising biomarkers for early detection and novel therapeutic targets to disrupt this lethal process.
In a paper published in MedComm – Future Medicine, a Chinese research team presents ImmunoCheckDB, a comprehensive web platform integrating meta-analysis and multiomic data to discover cancer immunotherapy biomarkers. The platform curates 173 studies on immune checkpoint inhibitor (ICI) therapies, covering survival outcomes for 93,234 individuals across 18 cancer types and 30 ICI regimens, enabling pan-cancer exploration of molecular markers for ICI efficacy.
Researchers have mapped the complex landscape of cytotoxic T lymphocytes (CTLs), revealing how their remarkable diversity and adaptability influence cancer immunotherapy outcomes. This comprehensive analysis identifies key biomarkers and regulatory pathways that could optimize personalized cancer treatments.
Researchers present a machine learning framework that forecasts individual mental health deterioration using limited, real-world data from wearables and smartphones. This enables personalized early interventions, shifting psychiatry from reactive to proactive care.
Researchers have successfully demonstrated that advanced generative AI (GenAI) models can accurately assess lung adenocarcinoma pathological features with remarkable precision. The comprehensive study shows Claude-3.5-Sonnet achieving 82.3% accuracy in cancer grading, potentially revolutionizing how pathologists diagnose and predict outcomes for lung cancer patients.
A research team from Southern Medical University has developed a machine learning-based gene model that predicts whether nasopharyngeal cancer (NPC) patients will benefit from radiotherapy. This predictive tool, called the NPC-RSS, was validated in both cell lines and patient samples. The model may guide personalized treatment decisions and improve survival outcomes for NPC patients.
A head-to-head study of five large language models (LLMs) shows that GPT-4, Claude-3.5 and Qwen-Max can correctly identify up to 75 percent of 13 thoracic diseases described in chest CT reports—outperforming earlier models and improving further with prompt design and fine-tuning. The findings point to faster, more reliable pre-operative planning for surgery.
A comprehensive review finds that GLP-1 receptor agonists, popular diabetes medications, show varying effects on cancer risk - protective against some cancers while potentially increasing risk for others. The findings emphasize the need for personalized treatment approaches.